Lavinia Negrea is a Nephrology physician affiliated with University Hospitals of Cleveland. OpenAlex indexes 37 publications with 2,044 citations (h-index 20).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
11100 Euclid Aveue
Cleveland, OH 44106
Telephone
216-844-8500Provider last certified this registry record 22 Nov 2020.
Industry payments
7 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Calliditas Therapeutics US Inc.Program year20251 payment
- Otsuka America Pharmaceutical, Inc.Program year20251 payment
- AKEBIA THERAPEUTICS INCProgram year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
55%Angiotensin receptor blocker (ARB)11.7%Losartan Potassium63%Olmesartan Medoxomil25%Valsartan13%Part D<11 patientsCalcium channel blocker10.9%Amlodipine Besylate79%Nifedipine Er21%Part D<11 patients+ 10 more classes in this area
Metabolism & gastrointestinal
28.3%SGLT2 inhibitor16.7%Farxiga62%Jardiance38%Part D<11 patientsVitamin D3 Analog6.9%Calcitriol100%Part D≥17 patients+ 3 more classes in this area
Other
6.5%Phosphate Binder6.5%Sevelamer Carbonate100%Part D≥14 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Serum Magnesium and Progression of Coronary Artery Calcification: A Report from the Chronic Renal Insufficiency Cohort (CRIC) Study
Journal of the American Society of Nephrology
2024 - SGLT2 Inhibitors and Mortality Risk in Individuals with Advanced CKD
Journal of the American Society of Nephrology
2024 - SGLT2 Inhibitors and Fracture Risk in Individuals with Advanced CKD
Journal of the American Society of Nephrology
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Michael Lederman, MD
University Hospitals of Cleveland
Anthony Furlan
University Hospitals of Cleveland
Joseph Sabik, MD
University Hospitals of Cleveland
Hans Luders
University Hospitals of Cleveland
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”